$NYMXF

$0.00 +$0.00 (0.0%) Close

$NYMXF Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 102.0M shares outstanding

Who owns NYMXF?

By type of holder

Institutions 54.6% Everyone else 45.4%

No insider has reported a holding in the last two years, so insiders are counted in "Everyone else".

Concentration Top 10 holders own 29.1%

BlackRock, Inc. 8.2% · Vanguard Portfolio Management LLC 3.8%

Institutional ownership

54.6%

-0.6 pts vs last qtr

Institutional holders

352

+14 vs last qtr

Net shares bought

−608.4K

by institutions in Q2 2026

New / sold out

62 / 48

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

Ancora Advisors LLC NEW +1.3M
Neuberger Berman Group LLC +990.9K

Biggest sellers in Q2 2026

Capital World Investors −2.4M
Royal Bank Of Canada −653.1K

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for Nymox Pharmaceutical Corp in the last 12 months.

Is your stake being diluted?

There are not yet two fiscal years of reported share counts for Nymox Pharmaceutical Corp.

How patient are the owners?

Institutional shares by how long they've been held

5+ years78% 3–5 years5% 1–3 years7% Under 1 year10%

Quarterly turnover

13.2%

of institutional shares changed hands

Top 10 managers, median time held

5 years

Super Investors

Investment managers reporting NYMXF on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
B BlackRock, Inc.	8.3M	8.15%	+280.8K (+3.5%)	≤2021	0.0%
Shares held by quarter Peak holding8.6M (Q4'24) Change over 8 quarters−37.7K Share of the company8.150% BlackRock, Inc.'s full portfolio →
VP Vanguard Portfolio Management LLC	3.8M	3.77%	+99.8K (+2.7%)	≤2021	0.0%
Shares held by quarter Peak holding3.8M (Q2'26) Change over 8 quarters+3.8M Share of the company3.770% Vanguard Portfolio Management LLC's full portfolio →

BlackRock, Inc.

8.3M

% of company

8.15%

Change vs last qtr

+280.8K (+3.5%)

Held since

≤2021

Vanguard Portfolio Management LLC

3.8M

% of company

3.77%

Change vs last qtr

+99.8K (+2.7%)

Held since

≤2021

28 more super investors behind a free account

See every manager holding Nymox Pharmaceutical Corp, how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting NYMXF on Form N-PORT; together they hold 29.2% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
IC iShares Core S&P Small-Cap ETF iShares Trust	$191M	3.3M	3.22%	0.17%	June 30, 2026
VT Vanguard Total Stock Market Index Fund Vanguard Index Funds	$101M	1.7M	1.70%	0.00%	June 30, 2026

iShares Core S&P Small-Cap ETF

iShares Trust

Position value

$191M

% of company

3.22%

% of the fund

0.17%

As of

June 30, 2026

Vanguard Total Stock Market Index Fund

Vanguard Index Funds

Position value

$101M

% of company

1.70%

% of the fund

0.00%

As of

June 30, 2026

23 more funds behind a free account

See every fund holding Nymox Pharmaceutical Corp and how much of the fund the position is.

Comments